William Polvino
Direktor/Vorstandsmitglied bei SAB BIOTHERAPEUTICS, INC.
Vermögen: - $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von William Polvino
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 20 | |
| Subsidiary | Pharmaceuticals: Major | 13 | |
SAB Sciences, Inc.
 SAB Sciences, Inc. Pharmaceuticals: MajorHealth Technology Part of SAB Biotherapeutics, Inc., SAB Sciences, Inc. operates as a clinical-stage biopharmaceutical development company. The company is based in Sioux Falls, SD. The company was founded in 2014 by Eddie J. Sullivan, Eddie Hamilton, Christine E. Hamilton. Eddie J. Sullivan has been the CEO since 2014. SAB Sciences was acquired by Big Cypress Acquisition Corp. on October 22, 2021 for $452.48 million.
11
| Subsidiary | Pharmaceuticals: Major | 11 |
Bridge Medicines LLC
 Bridge Medicines LLC Pharmaceuticals: MajorHealth Technology Bridge Medicines LLC operates as a drug discovery company. It provides spanning therapeutic areas including infectious disease, oncology, neuropsychiatry, and rare diseases. The company was founded on November 1, 2016 and is headquartered in New York, NY.
4
| Holding Company | Pharmaceuticals: Major | 4 |
Sapphire Therapeutics, Inc.
 Sapphire Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Sapphire Therapeutics, Inc. develops biopharmaceutical products. It develops compounds for the treatment of oncologic and metabolic diseases. The firm products include anamorelin for the treatment of anorexia and cachexia. The company was founded in 2000 and is headquartered in Bridgewater, NJ.
3
| Subsidiary | Pharmaceuticals: Major | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von William Polvino
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| CYMABAY THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chairman Director/Board Member | |
| Massachusetts Institute of Technology | College/University | Doctorate Degree Graduate Degree Undergraduate Degree | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| TREVI THERAPEUTICS, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| CORNERSTONE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| PFIZER, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
CTx Operations, Inc.
 CTx Operations, Inc. BiotechnologyHealth Technology CTx Operations, Inc. operates as a pre-clinical stage biotechnology company. It develops novel cellular therapeutics. The company was founded by Saar Gill and Michael Klichinsky in 2017 and is headquartered in Philadelphia, PA. | Biotechnology | Chairman Chairman | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
PharmAkea, Inc.
 PharmAkea, Inc. Pharmaceuticals: MajorHealth Technology PharmAkea, Inc. develops small molecule drug candidates against protein targets involved in fibro proliferative diseases. It discovers and develops small molecule therapeutics directed at cancer and fibrotic diseases. The company was founded by John Howard Hutchinson, Kevin Holme, and Jilly Evans in 2012 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| South Dakota Biotech Association | Director/Board Member Founder | ||
Renovis, Inc.
 Renovis, Inc. Pharmaceuticals: MajorHealth Technology Renovis, Inc. develops pharmaceutical products. The company discovers, develops, and commercializes novel therapeutics for neurological and inflammatory diseases. It is headquartered in San Francisco, CA | Pharmaceuticals: Major | Founder Director/Board Member | |
| Stanford University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Copenhagen | College/University | Graduate Degree Undergraduate Degree | |
| ALAUNOS THERAPEUTICS, INC. | Biotechnology | Chief Operating Officer Corporate Officer/Principal | |
| AVEO PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
| VALERITAS HOLDINGS, INC. | Medical Specialties | Director of Finance/CFO Comptroller/Controller/Auditor | |
Northwestern University
 Northwestern University Other Consumer ServicesConsumer Services Northwestern University is a private institution founded in 1851 to serve the Northwest Territory, an area that now includes the states of Ohio, Indiana, Illinois, Michigan, Wisconsin and parts of Minnesota. Northwestern has three campuses | College/University | Masters Business Admin Doctorate Degree | |
| University of Arizona | College/University | Masters Business Admin Undergraduate Degree | |
| Immtox LLC | Founder | ||
Novasenta, Inc.
 Novasenta, Inc. Miscellaneous Commercial ServicesCommercial Services Novasenta, Inc. develops therapies for cancer. The company is based in Pittsburgh, PA. The company was founded by Greg Delgoffe, Robert L. Ferris, Dario Vignali. Mani Mohindru has been the CEO of the company since 2021. | Miscellaneous Commercial Services | Chief Executive Officer | |
| CARDIFF ONCOLOGY, INC. | Medical Specialties | Director/Board Member | |
| CereXis, Inc. | Chief Executive Officer | ||
| CYTOMX THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| Axon Healthcare Ltd. | Corporate Officer/Principal | ||
| CARA THERAPEUTICS, INC. | Biotechnology | Director of Finance/CFO | |
| All India Institute of Medical Sciences | College/University | Graduate Degree | |
Circassia Ltd.
 Circassia Ltd. Pharmaceuticals: OtherHealth Technology Circassia Ltd. develops medicines for allergic and auto-immune diseases. The company was founded by Anthony Barrington Kay and Mark Larché on December 29, 1998 and is headquartered in Oxford, the United Kingdom. | Pharmaceuticals: Other | Director/Board Member | |
Xeltis AG
 Xeltis AG Medical SpecialtiesHealth Technology Xeltis AG develops medical devices to transform standards of care in heart valve replacement and vascular surgery. It develops fully bio absorbable synthetic heart valves and vascular grafts intended to enable for the first time the spontaneous growth of natural, healthy valves and vessels. Its medical device platform comprises bioabsorbable heart valves and blood vessels, designed to enable Endogenous Tissue Restoration (ETR), the natural restoration of the complex body part they replace upon implantation. The company was founded by Martijn Cox, Laurent Grandidier and Simon P. Hoerstrup in 2006 and is headquartered in Zurich, Switzerland. | Medical Specialties | Director/Board Member | |
| CURIS, INC. | Biotechnology | Investor Relations Contact | |
| NIOX GROUP PLC | Medical/Nursing Services | Director/Board Member | |
Credit Suisse Securities (USA) LLC (Broker)
 Credit Suisse Securities (USA) LLC (Broker) Investment Banks/BrokersFinance Credit Suisse Securities (USA) LLC (Credit Suisse Securities USA) is the broker/dealer division of Credit Suisse Securities (USA) LLC, an investment banking company headquartered in New York City. The firm was founded in 1998 and is a wholly owned subsidiary of Credit Suisse (USA), Inc., ultimately owned by Credit Suisse Group AG (SWX: CSGN) in Switzerland. Credit Suisse Securities USA offers a suite of equities, solutions and credit products and services which includes global securities sales, trading and execution, prime brokerage and comprehensive investment research. Their clients include financial institutions, corporations, governments, institutional investors, such as pension funds and hedge funds, and private individuals around the world. | Investment Banks/Brokers | Analyst-Equity | |
| NEOS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
UBS Securities LLC
 UBS Securities LLC Investment ManagersFinance UBS Securities LLC is an investment bank and registered broker/dealer headquartered in New York City. The firm was founded in 1998 as UBS Warburg LLC. They are a subsidiary of UBS Americas Holding LLC, ultimately held by UBS Group AG (SWX: UBSG, NYSE: UBS) in Switzerland. UBS Securities is a primary dealer in US Government securities and provides a full range of investment banking services which includes corporate finance, mergers and acquisitions, capital markets, trading and sales, fixed-income, equity research, private banking, underwriting and prime brokerage operations. The firm also provides advisory services and access to capital markets for corporate, institutional, intermediary and alternative asset management clients. | Investment Managers | Analyst-Equity | |
Spinogenix, Inc.
 Spinogenix, Inc. Pharmaceuticals: MajorHealth Technology Spinogenix, Inc. provides biotechnology services. It offers therapeutics, neurodegeneration, amyloids, traumatic brain injury and neurorestorative. The company was founded by Stella Sarraf in 2016 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Director/Board Member | |
| ADAGENE INC. | Pharmaceuticals: Major | Director/Board Member | |
Amydis, Inc.
 Amydis, Inc. Miscellaneous Commercial ServicesCommercial Services This technology allows physicians and researchers to explore the eye for a broad spectrum of diseases, which have previously required long-term clinical evaluation and invasive testing for definitive diagnosis. Amydis has a discovery platform and proprietary know-how that positions it as a first mover and leader in developing ocular tracers for human diseases. The American company was founded in 2013 by Stella Sarraf, who has been the CEO since then. | Miscellaneous Commercial Services | Director/Board Member | |
Lunac Therapeutics Ltd.
 Lunac Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Lunac Therapeutics Ltd. engages in the identification and development of anticoagulants. The company was founded by Helen Philippou and Richard Foster on April 18, 2018 and is headquartered in Leeds, the United Kingdom. | Pharmaceuticals: Major | Chairman |
Statistik
International
| Vereinigte Staaten | 43 |
| Vereinigtes Königreich | 4 |
| Indien | 3 |
| Dänemark | 2 |
| Schweiz | 2 |
Sektoral
| Health Technology | 31 |
| Finance | 7 |
| Consumer Services | 6 |
| Health Services | 3 |
| Commercial Services | 3 |
Operativ
| Director/Board Member | 261 |
| Corporate Officer/Principal | 108 |
| Independent Dir/Board Member | 80 |
| Chairman | 47 |
| Founder | 37 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Anthony Evnin | 46 |
| Carl Goldfischer | 31 |
| Mette Agger | 30 |
| Edward Penhoet | 29 |
| Bruce Peacock | 28 |
| Paul Edick | 27 |
| Michael Heffernan | 23 |
| Herbert Conrad | 21 |
| Christine Hamilton | 19 |
| Mervyn Turner | 18 |
| Craig Collard | 18 |
| Erick Lucera | 18 |
| Kurt Anker Nielsen | 18 |
| Michael King | 17 |
| Mani Mohindru | 15 |
- Börse
- Insiders
- William Polvino
- Unternehmensverbindungen
